CHRONIC
OBSTRUCTIVE PULMONARY
DISEASE (COPD)
Etiology, prevalence and types COPD is a major cause of mortality and morbidity worldwide and poses an increasing global healthcare problem (1) . The definition of COPD recognises the "abnormal", exaggerated or amplified inflammatory response in the lung and systemically to cigarette smoking and noxious pollutions (2) . The pattern of inflammation involves recruitment of lymphocytes, macrophages and neutrophils, as well as activation and damage to structural cells following the release of inflammatory chemokines and cytokines (2) (3) (4) (5) . In the Western world, the major driver of disease is cigarette smoke (CS) which is a complex mixture of organic chemicals, heavy metals and reactive oxygen species (ROS) (6) (7) (8) (9) (10) (11) . Importantly, Sopori (12) highlighted that chronic inhalation of cigarette smoke can modulate both innate and adaptive immune responses.
Moreover, it has been speculated that many of the health consequences of chronic cigarette smoking might be due to its adverse effects on the immune system (13) partially reversible (17, 18) . It is likely that CS-induced inflammation is responsible, at least in part, for this airflow limitation. Multiple intracellular signaling events occur by CS, which ultimately leads to the synthesis and release of
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Tanaffos 2012; 11 (4) : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] pro-inflammatory mediators, such as interleukin-8 (IL-8)/CXCL8, IL-1β, and tumor necrosis factor-α TNF-α) (19, 20) . CXCL8 levels, for example, are markedly increased in induced sputum of patients with COPD and this increase correlates with the increased proportion of neutrophils (22) (23) (24) (25) (26) .
Besides CXCL8 and other inflammatory cytokines and chemokines, there is evidence for enhanced presence of markers of oxidative stress in COPD including nitric oxide (NO) (27) , hydrogen peroxide (27) and lipid peroxidation products (28, 29) in COPD patients. NO is generated in COPD from the enzyme inducible NO synthase (NOS2), which is expressed in macrophages and lung parenchyma of patients with COPD, particularly in patients with severe disease (30) . In addition, there is increased expression of neuronal NOS (NOS1) in these patients (31) . NO is markedly increased in exhaled breath of patients with mild asthma, reflecting the inflammatory process in the airways (31) but in patients with COPD exhaled NO levels are little raised above normal (32, 33) but are more clearly increased during exacerbations (32) . This may reflect formation of nitrotyrosine adducts which are markedly increased in COPD (14) .
COPD in Never Smokers
Since the 1950s tobacco smoking has been linked to COPD (17) and smoking has long been widely considered as the single most important risk factor for COPD. A great percentage of COPD mortality and morbidity in both genders can be attributed to cigarette smoking (14) .
Because of such well-association, a number of studies have concentrated on the role of smoking in COPD, focusing only on smokers, in particular, those with at least 20 packyears of cigarette smoking exposure (34) .
However, published data in recent years demonstrate a significant prevalence of COPD among never smokers.
Increasing evidence suggests that non-smokers may account for between one fourth and one third of all COPD cases in contrast to the 50-70% whose COPD is smokingrelated (37) (38) (39) (40) . This prevalence varies across nations in both developed and developing regions and mainly relates to exposure to indoor pollution (35 had poor ventilation in the kitchen (45) . This compares with the first study detailing the bronchopulmonary characteristics of 10 Iranian women who were exposed to the indoor smoke published by Amoli in 1998 (46) .
There may be some variability in the presentation of COPD in patients who are never smokers but exposed to biomass smoke. In a large epidemiological study in China the prevalence of COPD in non-smokers was 5.2%.
Exposure to biomass smoke and the presence of poor ventilation in the kitchen were independently associated with a higher risk of COPD among non-smokers.
Interestingly, non-smokers with COPD were less likely to present with chronic productive coughs and lower BMI, while more likely to have received a physician diagnosis of asthma and respiratory diseases in childhood, than Overall, females older than 55, with a previous history of a respiratory disease and without expectoration or wheezing predominate in populations characterized as having COPD despite being never smokers (48) .
Furthermore, charcoal workers exposed to wood smoke have increased respiratory symptoms and decreased pulmonary function (49) .
A Brazilian study of 1402 subjects has reported that the amount of particulate matter less than 2.5μm in diameter (PM2.5), whether from indoor or outdoor biomass fuel, was associated with worse lung function, greater respiratory symptoms and the development of COPD.
These effects were associated with the duration and magnitude of biomass exposure and were exacerbated by tobacco smoke. This was not seen in individuals from the same community exposed to liquefied petroleum gas (50) .
In a similar manner, Turkish women from rural areas exposed to biomass fumes were more likely to suffer from chronic bronchitis and COPD than women from urban areas even though the incidence of cigarette smoking was much greater in the urban population (51) . was greatest if subjects were exposed to both wood and charcoal (54).
Furthermore, the incidence of non-smoking COPD (GOLD stage 2) in Northern Sweden reached 7% in almost 2000 subjects studied and was associated with increasing age but not sex or exposure to environmental tobacco smoke. Of those subjects with airway obstruction as defined by GOLD, 14% of men and 27% of women had never smoked (56) . The authors did not report on biomass or wood smoke exposure in these subjects. Although use of biomass fuel for cooking is not common in Western
Europe, exposure to air pollutants in workplaces such as farming, coal mining, construction, gold mining, plastic, textile, rubber, leather manufacturing, manufacture of food products and automotive repair have been shown to be important and may account for the incidence of COPD in non-smokers in the UK and other parts of Europe (57) .
Is the immunological profile of COPD due to indoor pollution the same as that due to cigarette smoke?
The immune cells involved in COPD development and progression have been summarized in several excellent reviews (58, 59) . Innate immune cells such as epithelial 
Autoimmunity and emphysema
The description of increased B-cell follicles in more advanced COPD (69) emphasized the possible importance of an autoimmune component in COPD pathology (27, 59) . particularly with emphysema (78) . Importantly, emphysematous patients produced autoantibodies of both higher titre and reactivity than those of control subjects.
One possibility to account for these differences is that the autoantibodies are mainly directed against oxidative stress-modified self-proteins and that epitope spreading occurs to allow variable detection of autoantibodies against unmodified protein (27) . This study also reported autoantibodies against endothelial cells and deposition of activated complement in the vessels of COPD lung (27) . It is generally held that, by definition, airway obstruction in COPD is irreversible. However, significant BDR is in fact present in a large subgroup of patients with COPD, although they are mainly screened out from therapeutic studies (96, 97, ) . Some investigators have suggested that this BDR feature in COPD is related to "asthma-like" pathology, i.e. an overlap syndrome (98, 99) ). A substantial number of COPD subjects have been shown to have BHR (100, 101) with a significant correlation between BDR and BHR (102) . Recently, it has been shown that in COPD subjects without BDR, there was a positive relationship between mast cell density and better airway function (89) . In this regard we were not able to rule out the role of eosinophils in BDR reaction since it has been shown that high sputum eosinophil count did identify a subgroup of patients with COPD who respond to inhaled corticosteroids in terms of lung function.
In summary, despite the heterogeneity across the selected studies, exposure to solid fuel smoke is consistently associated with COPD and chronic bronchitis.
Women using biomass fuel for cooking typically spend about 40,000 hours and inhale a total volume of 25 million litres of polluted air during their lifetime (57) . A recent meta-analysis has reported that the odds of COPD in biomass smoke exposed individuals is of a similar magnitude to that reported between tobacco smoking and COPD (57) . The limited evidence available to date suggests that the pathology of biomass-induced and cigarette smoke-induced COPD are the same. This suggests that the prognosis and response to inhaled β 2 -agonists and combination therapy should be similar in these groups of patients. We await the development of better antiinflammatory treatments for COPD in order to prevent the inexorable progression of disease seen in these patients.
